Fundraising Fox

Chad W. Souvignier

Investor

Vice President at Research Corporation Technologies

Tucson

About

Souvignier performs scientific and business analysis of early-stage biomedical investment opportunities and manages a portfolio of RCT projects and investments, focusing on life science tools and therapeutics. He has held roles at RCT since 2003, previously worked at Guilford Pharmaceuticals, and holds a Ph.D. in Materials Science and an MBA from the University of Arizona.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Investments

Board seats

Biolog, Inc.Calosyn Pharmaceuticals Inc.Esperance Pharmaceuticals, Inc.Halo Labs, Inc.Jenrin Discovery Inc.Seqwell, IncTD2

Per the firm's website.

Colleagues at Research Corporation Technologies

Frequently asked questions

Who is Chad W. Souvignier?
Souvignier performs scientific and business analysis of early-stage biomedical investment opportunities and manages a portfolio of RCT projects and investments, focusing on life science tools and therapeutics. He has held roles at RCT since 2003, previously worked at Guilford Pharmaceuticals, and holds a Ph.D. in Materials Science and an MBA from the University of Arizona.
Where does Chad W. Souvignier work?
Chad W. Souvignier is Vice President at Research Corporation Technologies.
What does Chad W. Souvignier invest in?
Chad W. Souvignier invests in Biotech, Healthtech, Medical Devices.
What boards does Chad W. Souvignier sit on?
Chad W. Souvignier holds tracked board seats at Biolog, Inc., Calosyn Pharmaceuticals Inc., Esperance Pharmaceuticals, Inc., Halo Labs, Inc., Jenrin Discovery Inc., Seqwell, Inc, TD2.